Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 4 months ago

Possible Interaction: Cyproterone and Adrenocorticotropic Hormone

Research Papers that Mention the Interaction

The combination of agonist and receptor blocker is attractive particularly when the receptor blocker like cyproterone acetate also suppresses the release of LH, FSH and adrenocorticotrophic hormone.
Bailliere's clinical endocrinology and metabolism  •  1987  |  View Paper
Elevated ACTH concentrations were suppressed by prednisolone (25%), dexamethasone (2% of the hydrocortisone dose) or by addition of cyproterone acetate (100 mg/m2/day).
Acta endocrinologica. Supplementum  •  1986  |  View Paper
ACTH increased significantly unconjugated DT levels during ingestion of CPA , but not in pretreatment.
Contraception  •  1979  |  View Paper
The results suggest that CPA has a twofold effect leading to adrenocortical insufficiency: i.e., inhibition of cortisol secretion by the adrenals themselves and inhibition of ACTH secretion at the hypothalamo-pituitary level.
European Journal of Pediatrics  •  1978  |  View Paper
Cyproteroneacetate , an antiandrogenic and gonadotropin-inhibiting steroid, has a marked ACTH suppressive effect.
In 10 patients with endogenous elevated plasma ACTH, 10 days of treatment with cyproteroneacetate , in addition to the steroid substitution, diminished the morning plasma ACTH levels.
In 25 human volunteers, a single dose of 200 mg cyproteroneacetate impaired their ACTH and 11-deoxycorticosteroid response to 1 g metyrapone.
The Journal of clinical endocrinology and metabolism  •  1978  |  View Paper
Cyproterone acetate (CA) inhibited 1-24 ACTH (50 ng/l)-stimulated cortisol production by dispersed guinea-pig adrenal cells in a dose-related manner.
Biochemical pharmacology  •  1985  |  View Paper
It is believed the antiandrogen cyproterone acetate inhibited ACTH synthesis and release and that this was responsible for adrenocortical atrophy.
Archives of andrology  •  1980  |  View Paper
It is believed that cyproterone acetate inhibited adrenocortical steroidogenesis by interfering with pituitary release of ACTH.
Archives of andrology  •  1980  |  View Paper
Furthermore, indirect evidence from the mass and morphology of the adrenal suggests that cyproterone acetate may also suppress production or secretion of ACTH by the pituitary gland.
The Journal of endocrinology  •  1979  |  View Paper
CA also significantly inhibited the increase in prostatic weight that occurred after 14 days of administration of ACTH (20 U⁄day), prolactin (1 mg⁄day) plus ACTH (5 mg⁄day), or prolactin (1 mg⁄day) plus DHA (0.2 mg⁄day).
Endocrinology  •  1970  |  View Paper